Privi Speciality Chemicals Ltd. announced on June 14, 2025, that it will not proceed with a capital raising of up to ₹1,000 crores due to sufficient cash flows, and approved a merger with related parties Privi Fine Sciences and Privi Biotechnologies, subject to shareholder and regulatory approvals.